Detailed Mechanism Funding and Narrative

Years of mechanism: 2016 2017 2018 2019 2020

Details for Mechanism ID: 18237
Country/Region: Tanzania
Year: 2017
Main Partner: Deloitte Consulting Limited
Main Partner Program: NA
Organizational Type: Private Contractor
Funding Agency: USAID
Total Funding: $6,982,486 Additional Pipeline Funding: $10,000,000

NOTE: PEPFAR no longer creates activity narratives for each mechanism. In their place, PEPFAR has begun releasing mechanism specific targets that reveal the achievements and programs that are expected of the funding. If available for this mechanism, these targets are presented below.

Mechanism Allocation by Budget Code for Selected Year
Care: Adult Care and Support (HBHC) $0
Care: TB/HIV (HVTB) $802,965
Care: Pediatric Care and Support (PDCS) $204,846
Laboratory Infrastructure (HLAB) $120,000
Testing: HIV Testing and Counseling (HVCT) $461,648
Biomedical Prevention: Prevention of Mother to Child Transmission (MTCT) $5,538
Treatment: Adult Treatment (HTXS) $4,495,800
Treatment: Pediatric Treatment (PDTX) $891,689
Mechanism Target Information

Since COP2014, PEPFAR no longer produces narratives for every mechanism it funds. However, PEPFAR has now included performance targets or indicator information for each mechanism based on the Monitoring, Evaluation, and Reporting (MER) system. The MER guidance is available on PEPFAR's website https://www.pepfar.gov/reports/guidance/. Note that COP years 2014-2015 were under a previous version of the MER system and the indicators and definitions may have changed as of the new 2.0 guidance.

MER Indicator MER description Target Fiscal Year Target
GEND_GBV By PEP service provision (related to sexual violence services provided) 2018 1,237
GEND_GBV By type of service: Physical and/or Emotional Violence (Other Post-GBV Care) 2018 20,079
GEND_GBV By type of service: Sexual Violence (Post-Rape Care) 2018 1,258
GEND_GBV Number of people receiving post-GBV care 2018 22,561
HTS_TST Number of individuals who received T&C services for HIV and received their test results during the past 12 months 2018 796,904
HTS_TST Service Delivery Point (Facility) Malnutrition: Negative 2018 2,686
HTS_TST Service Delivery Point (Facility) Pediatric : <5 Negative 2018 7,394
HTS_TST Service Delivery Point Agg Age (Facility) Index: <15, Female, Negative 2018 15,188
HTS_TST Service Delivery Point Agg Age (Facility) Index: <15, Male, Negative 2018 14,560
HTS_TST Service Delivery Point Agg Age (Facility) Index: 15+, Female, Negative 2018 18,697
HTS_TST Service Delivery Point Agg Age (Facility) Index: 15+, Male, Negative 2018 8,686
HTS_TST Service Delivery Point by Agg Age (Facility) ANC: 15+, Negative 2018 118,248
HTS_TST Service Delivery Point by Agg Age (Facility) Inpatient: <15, Female, Negative 2018 22,551
HTS_TST Service Delivery Point by Agg Age (Facility) Inpatient: <15, Male, Negative 2018 21,670
HTS_TST Service Delivery Point by Agg Age (Facility) Inpatient: 15+, Female, Negative 2018 13,864
HTS_TST Service Delivery Point by Agg Age (Facility) Inpatient: 15+, Male, Negative 2018 6,153
HTS_TST Service Delivery Point by Agg Age (Facility) Other PITC: <15, Female, Negative 2018 35,230
HTS_TST Service Delivery Point by Agg Age (Facility) Other PITC: <15, Male, Negative 2018 34,128
HTS_TST Service Delivery Point by Agg Age (Facility) Other PITC: 15+, Female, Negative 2018 285,864
HTS_TST Service Delivery Point by Agg Age (Facility) Other PITC: 15+, Male, Negative 2018 131,494
HTS_TST Sum of Test Result disaggregates 2018 49,058
HTS_TST_POS By Test Result: Positive 2018 49,058
HTS_TST_POS Service Delivery Point (Facility) Malnutrition: Positive 2018 14
HTS_TST_POS Service Delivery Point (Facility) Pediatric : <5 Positive 2018 80
HTS_TST_POS Service Delivery Point Agg Age (Facility) Index: <15, Female, Positive 2018 205
HTS_TST_POS Service Delivery Point Agg Age (Facility) Index: <15, Male, Positive 2018 198
HTS_TST_POS Service Delivery Point Agg Age (Facility) Index: 15+, Female, Positive 2018 5,594
HTS_TST_POS Service Delivery Point Agg Age (Facility) Index: 15+, Male, Positive 2018 2,633
HTS_TST_POS Service Delivery Point by Agg Age (Facility) ANC: 15+, Positive 2018 4,425
HTS_TST_POS Service Delivery Point by Agg Age (Facility) Inpatient: <15, Female, Positive 2018 342
HTS_TST_POS Service Delivery Point by Agg Age (Facility) Inpatient: <15, Male, Positive 2018 323
HTS_TST_POS Service Delivery Point by Agg Age (Facility) Inpatient: 15+, Female, Positive 2018 1,052
HTS_TST_POS Service Delivery Point by Agg Age (Facility) Inpatient: 15+, Male, Positive 2018 482
HTS_TST_POS Service Delivery Point by Agg Age (Facility) Other PITC: <15, Female, Positive 2018 669
HTS_TST_POS Service Delivery Point by Agg Age (Facility) Other PITC: <15, Male, Positive 2018 657
HTS_TST_POS Service Delivery Point by Agg Age (Facility) Other PITC: 15+, Female, Positive 2018 22,060
HTS_TST_POS Service Delivery Point by Agg Age (Facility) Other PITC: 15+, Male, Positive 2018 10,678
PMTCT_ART Already on ART at beginning of current pregnancy 2018 2,769
PMTCT_ART New on ART 2018 5,037
PMTCT_ART Number of HIV-positive pregnant women who received ART to reduce risk of mother-to-child-transmission (MTCT) during pregnancy 2018 7,806
PMTCT_ART Number of pregnant women with known HIV status (includes women who were tested for HIV and received their results) 2018 126,217
PMTCT_EID Number of infants who had a virologic HIV test within 12 months of birth during the reporting period 2018 7,769
PMTCT_EID Number of infants with a negative virological test result between 2 and 12 months of birth 2018 1,790
PMTCT_EID Number of infants with a negative virological test result within 2 months of birth 2018 5,756
PMTCT_EID Number of infants with a positive virological test result between 2 and 12 months of birth 2018 84
PMTCT_EID Number of infants with a positive virological test result within 2 months of birth 2018 119
PMTCT_EID Unknown, <= 2 months 2018 15
PMTCT_EID Unknown, 2 - 12 months 2018 5
PMTCT_STAT By Age (Numerator): 25-49 2018 17,777
PMTCT_STAT By Age (Numerator): Unknown Age 2018 76,778
PMTCT_STAT By Number of known positives: 25-49 2018 1,009
PMTCT_STAT By Number of known positives: Unknown Age 2018 2,816
PMTCT_STAT By Number of new negative: 25-49 2018 15,836
PMTCT_STAT By Number of new negative: Unknown Age 2018 101,608
PMTCT_STAT By Number of new positives: 25-49 2018 1,021
PMTCT_STAT By Number of new positives: Unknown Age 2018 3,388
PMTCT_STAT Number of pregnant women with known HIV status (includes women who were tested for HIV and received their results) 2018 126,217
PMTCT_STAT_den By Age (Denominator): 25-49 2018 18,807
PMTCT_STAT_den By Age (Denominator): Unknown Age 2018 117,276
TB_PREV By Age/Sex (Numerator): <15, Female 2018 581
TB_PREV By Age/Sex (Numerator): <15, Male 2018 891
TB_PREV By Age/Sex (Numerator): 15+, Female 2018 5,545
TB_PREV By Age/Sex (Numerator): 15+, Male 2018 8,263
TB_PREV By Therapy type (Numerator): 6-12 Month IPT 2018 15,282
TB_PREV The number of ART patients who completed a course of TB preventive therapy or at least 6 months of Isoniazid Preventive Therapy (IPT) during the reporting period 2018 15,287
TB_PREV The number of ART patients who were newly started on TB preventive therapy (including those who newly started on TB preventive therapy in this reporting period and those who started in the previous reporting period but had not been reported as they did not fulfill the minimum requirements for the previous reporting period) 2018 30,580
TB_PREV_den By Age/Sex (Denominator): <15, Female 2018 1,195
TB_PREV_den By Age/Sex (Denominator): <15, Male 2018 1,815
TB_PREV_den By Age/Sex (Denominator): 15+, Female 2018 11,036
TB_PREV_den By Age/Sex (Denominator): 15+, Male 2018 16,491
TB_PREV_den By Therapy type (Denominator): 6-12 Month IPT 2018 30,501
TX_CURR Aggregated Age/Sex: <15 Female 2018 6,282
TX_CURR Aggregated Age/Sex: <15 Male 2018 6,471
TX_CURR Aggregated Age/Sex: 15+ Female 2018 117,676
TX_CURR Aggregated Age/Sex: 15+ Male 2018 52,247
TX_CURR Number of adults and children receiving antiretroviral therapy (ART) 2018 182,681
TX_CURR Sum of Aggregated Age/Sex <15 2018 12,753
TX_CURR Sum of Aggregated Age/Sex 15+ 2018 169,923
TX_CURR Sum of Aggregated Age/Sex disaggregates 2018 182,676
TX_NEW Aggregated Grouping by Age/Sex: <15 Female 2018 1,555
TX_NEW Aggregated Grouping by Age/Sex: <15 Male 2018 1,565
TX_NEW Aggregated Grouping by Age/Sex: 15+ Female 2018 32,946
TX_NEW Aggregated Grouping by Age/Sex: 15+ Male 2018 14,467
TX_NEW Breastfeeding status 2018 350
TX_NEW By Age/Sex: 25-49 Female 2018 26
TX_NEW Number of adults and children newly enrolled on antiretroviral therapy (ART) 2018 50,576
TX_NEW Pregnancy status 2018 2,714
TX_NEW Sum of Age/Sex disaggregates 2018 26
TX_NEW Sum of Aggregated Age/Sex disaggregates 2018 50,533
TX_PVLS <15, Routine, Unknown Sex 2018 3
TX_PVLS 15+, Routine, Unknown Sex 2018 46
TX_PVLS 15+, Targeted, Unknown Sex 2018 5
TX_PVLS 15+, Undocumented Test Indication, Female 2018 1
TX_PVLS 15+, Undocumented Test Indication, Male 2018 1
TX_PVLS Number of adult and pediatric ART patients with a viral load result documented in the patient medical record and /or laboratory records in the past 12 months 2018 137,674
TX_PVLS Number of adults and pediatric patients on ART with suppressed viral load results (<1,000 copies/ml) documented in the medical records and /or supporting laboratory results within the past 12 months 2018 123,571
TX_PVLS Numerator: Aggregate Age/Sex by Indication: <15 Female Routine 2018 3,755
TX_PVLS Numerator: Aggregate Age/Sex by Indication: <15 Female Targeted 2018 430
TX_PVLS Numerator: Aggregate Age/Sex by Indication: <15 Male Routine 2018 4,032
TX_PVLS Numerator: Aggregate Age/Sex by Indication: <15 Male Targeted 2018 431
TX_PVLS Numerator: Aggregate Age/Sex by Indication: 15+ Female Routine 2018 71,286
TX_PVLS Numerator: Aggregate Age/Sex by Indication: 15+ Female Targeted 2018 7,974
TX_PVLS Numerator: Aggregate Age/Sex by Indication: 15+ Male Routine 2018 31,899
TX_PVLS Numerator: Aggregate Age/Sex by Indication: 15+ Male Targeted 2018 3,535
TX_PVLS Numerator: Indication: Routine 2018 111,208
TX_PVLS Numerator: Indication: Targeted 2018 12,363
TX_PVLS Numerator: Preg/BF by Indication: Breastfeeding Routine 2018 180
TX_PVLS Numerator: Preg/BF by Indication: Breastfeeding Targeted 2018 116
TX_PVLS Numerator: Preg/BF by Indication: Pregnant Routine 2018 2,371
TX_PVLS Numerator: Preg/BF by Indication: Pregnant Targeted 2018 125
TX_PVLS_den Denominator: Aggregate Age/Sex by Indication: <15 Female Routine 2018 4,253
TX_PVLS_den Denominator: Aggregate Age/Sex by Indication: <15 Female Targeted 2018 446
TX_PVLS_den Denominator: Aggregate Age/Sex by Indication: <15 Male Routine 2018 4,431
TX_PVLS_den Denominator: Aggregate Age/Sex by Indication: <15 Male Targeted 2018 468
TX_PVLS_den Denominator: Aggregate Age/Sex by Indication: 15+ Female Routine 2018 79,726
TX_PVLS_den Denominator: Aggregate Age/Sex by Indication: 15+ Female Targeted 2018 8,873
TX_PVLS_den Denominator: Aggregate Age/Sex by Indication: 15+ Male Routine 2018 35,440
TX_PVLS_den Denominator: Aggregate Age/Sex by Indication: 15+ Male Targeted 2018 3,944
TX_PVLS_den Denominator: Indication: Routine 2018 123,840
TX_PVLS_den Denominator: Indication: Targeted 2018 13,791
TX_PVLS_den Denominator: Preg/BF by Indication: Breastfeeding Routine 2018 225
TX_PVLS_den Denominator: Preg/BF by Indication: Breastfeeding Targeted 2018 110
TX_PVLS_den Denominator: Preg/BF by Indication: Pregnant Routine 2018 2,668
TX_PVLS_den Denominator: Preg/BF by Indication: Pregnant Targeted 2018 133
TX_RET Aggregated Age/Sex: <15 Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2018 1,227
TX_RET Aggregated Age/Sex: <15 Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2018 1,150
TX_RET Aggregated Age/Sex: 15+ Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2018 17,166
TX_RET Aggregated Age/Sex: 15+ Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2018 8,092
TX_RET Number of adults and children who are still alive and on treatment at 12 months after initiating ART 2018 27,646
TX_RET Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up 2018 32,470
TX_RET_den Aggregated Age/Sex: <15 Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2018 1,411
TX_RET_den Aggregated Age/Sex: <15 Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2018 1,320
TX_RET_den Aggregated Age/Sex: 15+ Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2018 20,209
TX_RET_den Aggregated Age/Sex: 15+ Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2018 9,497
TX_TB Number of ART patients who were screened for TB at least once during the reporting period 2018 174,265
TX_TB Number of ART patients who were started on TB treatment during the reporting period 2018 4,368
TX_TB Numerator: By Aggregated Age/Sex: <15, Female 2018 153
TX_TB Numerator: By Aggregated Age/Sex: <15, Male 2018 233
TX_TB Numerator: By Aggregated Age/Sex: 15+, Female 2018 1,587
TX_TB Numerator: By Aggregated Age/Sex: 15+, Male 2018 2,336
TX_TB_den Denominator: By Aggregated Age/Sex: <15, Female 2018 4,901
TX_TB_den Denominator: By Aggregated Age/Sex: <15, Male 2018 7,357
TX_TB_den Denominator: By Aggregated Age/Sex:15+, Female 2018 44,339
TX_TB_den Denominator: By Aggregated Age/Sex:15+, Male 2018 66,191
TX_TB_den Denominator: By Screen Result: Negative 2018 169,804
TX_TB_den Denominator: By Screen Result: Positive 2018 4,348
TX_TB_den Denominator: Number of ART patients who had a specimen sent for bacteriologic diagnosis of active TB disease 2018 5
Cross Cutting Budget Categories and Known Amounts Total: $2,905,568
Gender: Gender Based Violence (GBV) $1,435,068
GBV Prevention
Collection and Use of Gender-related Strategic Information
Implementation
Capacity building
Monitoring and Evaluation
Post GBV Care
Collection and Use of Gender-related Strategic Information
Implementation
Capacity building
Monitoring and Evaluation
Gender: Gender Equality $1,398,000
Changing harmful gender norms and promoting positive gender norms
Collection and Use of Gender-related Strategic Information
Implementation
Capacity building
Monitoring and Evaluation
Promoting gender-related policies and laws that increase legal protection
Collection and Use of Gender-related Strategic Information
Implementation
Capacity building
Monitoring and Evaluation
Increase gender-equitable access to income and productive resources, including education
Collection and Use of Gender-related Strategic Information
Implementation
Capacity building
Monitoring and Evaluation
Equity in HIV prevention, care, treatment and support
Collection and Use of Gender-related Strategic Information
Implementation
Capacity building
Monitoring and Evaluation
Water $72,500